This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Oct;62(10):1133-1134.

doi: 10.1111/ped.14423.

What are the main revised points in the 6th diagnostic guidelines for Kawasaki disease?

Affiliations

PMID: 33089574
DOI: 10.1111/ped.14423

Editorial

What are the main revised points in the 6th diagnostic guidelines for Kawasaki disease?

Masaaki Mori. Pediatr Int. 2020 Oct.

. 2020 Oct;62(10):1133-1134.

doi: 10.1111/ped.14423.

Author

Affiliation

¹ Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

PMID: 33089574
DOI: 10.1111/ped.14423

No abstract available

PubMed Disclaimer

Similar articles

Revision of diagnostic guidelines for Kawasaki disease (6th revised edition).
Kobayashi T, Ayusawa M, Suzuki H, Abe J, Ito S, Kato T, Kamada M, Shiono J, Suda K, Tsuchiya K, Nakamura T, Nakamura Y, Nomura Y, Hamada H, Fukazawa R, Furuno K, Matsuura H, Matsubara T, Miura M, Takahashi K. Kobayashi T, et al. Pediatr Int. 2020 Oct;62(10):1135-1138. doi: 10.1111/ped.14326. Epub 2020 Oct 1. Pediatr Int. 2020. PMID: 33001522 No abstract available.
Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition).
Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Ishii M, Harada K; Kawasaki Disease Research Committee. Ayusawa M, et al. Pediatr Int. 2005 Apr;47(2):232-4. doi: 10.1111/j.1442-200x.2005.02033.x. Pediatr Int. 2005. PMID: 15771703
[The mucocutaneous lymph node syndrome or Kawasaki disease].
Wuilloud AH, Schilt U, Rossi E. Wuilloud AH, et al. Helv Paediatr Acta. 1979 May;34(2):161-6. Helv Paediatr Acta. 1979. PMID: 457431 German.
Calculated decisions: Kawasaki disease diagnostic criteria.
Brown J, Cavanna A. Brown J, et al. Pediatr Emerg Med Pract. 2020 Feb 2;17(1):CD1-CD2. Pediatr Emerg Med Pract. 2020. PMID: 32065518 Review.
Mucocutaneous lymph node syndrome (Kawasaki syndrome): a case report.
Gültekin A, Gökalp A, Oğuz A, Hah MM. Gültekin A, et al. Turk J Pediatr. 1988 Jan-Mar;30(1):51-4. Turk J Pediatr. 1988. PMID: 3068866 Review. No abstract available.

See all similar articles

Cited by

The Benefits and Respective Side-Effects of PE Therapy for Intractable Kawasaki Disease.
Mori M, Yamazaki S, Naruto T. Mori M, et al. J Clin Med. 2021 Mar 4;10(5):1062. doi: 10.3390/jcm10051062. J Clin Med. 2021. PMID: 33806522 Free PMC article. Review.

References

1. Kobayashi T, Ayusawa M, Suzuki H, et al. Revision of diagnostic guidelines for Kawasaki disease (6th revised edition). Pediatr. Int. 2020; 62: 1135-8.
1. Ayusawa M, Sonobe T, Uemura S et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr. Int. 2005; 47: 232-4.
1. Fuse S, Mori T, Kuroiwa Y et al. On what day of illness does the dilatation of coronary arteries in patients with Kawasaki disease begin? Circ. J. 2018; 82: 247-50.
1. Uehara R. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site. Pediatr. Infect. Dis. J. 2010; 29: 430-3.

Publication types

Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information